Epigral — 360° view

Epigral, a company in the Specialty Chemicals industry, reported revenue of ₹746 crore and net profit of ₹64 crore for the September 2026 quarter.

Epigral (NSE: EPIGRAL) closed at ₹928.30 on 20 Nov 2026, down 36.2% over the past year. Its market capitalisation is ₹4,005 crore and it trades at 14.1 times earnings.

Share price
₹928.30 (20 Nov 2026)
Market cap
₹4,005 Cr (20 Nov 2026)
P/E
14.07 (20 Nov 2026)
Revenue
₹746 Cr (September 2026 quarter)
Net profit
₹64 Cr (September 2026 quarter)
ROCE
15.3% (FY26)
ROE
15.8% (FY26)
Book value
₹548 (FY26)
Dividend yield
0.54% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,535.20 / ₹807.00 (20 Nov 2026)
1-year return
-36.2% (to 20 Nov 2026)
Sector
Commodities
Industry
Specialty Chemicals
Symbol
NSE: EPIGRAL

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.